https://nl.marketscreener.com/koers/aandeel/ULTRAGENYX-PHARMACEUTICAL-15672076/nieuws/GeneTx-Biotherapeutics-LLC-en-Ultragenyx-Pharmaceutical-Inc-Voorlopige-Update-over-Fase-1-2-Klinisc-37480881/?utm_source=telegram&utm_medium=social&utm_campaign=share